A Day Up For Xenon Pharmaceuticals Inc.
Mon, Mar 09, 2026 at 07:26 PM
Xenon Pharmaceuticals Inc. (XENE:NASDAQ) shot up at $62.76, representing a gain of 49.6%. On Mon, Mar 09, 2026, XENE:NASDAQ touched a New 2-Week High of $62.76. The stock got featured on our News Catalysts scanner on Mon, Mar 09, 2026 at 06:49 PM in the 'PUBLIC OFFERING' category. From Mon, Feb 23, 2026, the stock recorded 40.00% Up Days and 54.55% Green Days
About Xenon Pharmaceuticals Inc. (XENE:NASDAQ)
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its products portfolio includes Glybera, TV-45070.
Top 10 Gainers:
- Garden Stage Limited (GSIW:NASDAQ), 248.11%
- Autozi Internet Technology (Global) Ltd. (AZI:NASDAQ), 146.4%
- AN2 Therapeutics, Inc. (ANTX:NASDAQ), 84.21%
- Davis Commodities Limited (DTCK:NASDAQ), 74.13%
- POMDOCTOR LIMITED (POM:NASDAQ), 74.07%
- Xenon Pharmaceuticals Inc. (XENE:NASDAQ), 49.64%
- CAMP4 THERAPEUTICS CORPORATION (CAMP:NASDAQ), 49.4%
- XCF Global Inc. (SAFX:NASDAQ), 46.2%
- Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 45.9%
- Hims & Hers Health, Inc. (HIMS:NYSE), 40.79%